Allevion Medical Gains FDA 510(k) for Vantage System
BOCA RATON, Fla., April 1, 2026 Allevion Medicalâ„¢ announced that the U.S. Food and Drug Administration (FDA) has granted...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
BOCA RATON, Fla., April 1, 2026 Allevion Medicalâ„¢ announced that the U.S. Food and Drug Administration (FDA) has granted...
Dateline: November 17, 2025 — Lisle, IllinoisHubly Surgical Inc. announced that the Auto-Stop Drill, its cordless surgical tool equipped...
LISLE, Ill., Nov. 12, 2025—Hubly Surgical announced that its Hubly Auto-Stop Drill has received FDA 510(k) clearance expanding the...
